ATE277631T1 - Neospora impstoff - Google Patents

Neospora impstoff

Info

Publication number
ATE277631T1
ATE277631T1 AT98306431T AT98306431T ATE277631T1 AT E277631 T1 ATE277631 T1 AT E277631T1 AT 98306431 T AT98306431 T AT 98306431T AT 98306431 T AT98306431 T AT 98306431T AT E277631 T1 ATE277631 T1 AT E277631T1
Authority
AT
Austria
Prior art keywords
neospora vaccine
neospora
vaccine
Prior art date
Application number
AT98306431T
Other languages
English (en)
Inventor
David Alan Brake
Manuel Campos
Original Assignee
Pfizer Prod Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=22007613&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ATE277631(T1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Pfizer Prod Inc filed Critical Pfizer Prod Inc
Application granted granted Critical
Publication of ATE277631T1 publication Critical patent/ATE277631T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/002—Protozoa antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/20—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans from protozoa
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Immunology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Epidemiology (AREA)
  • Mycology (AREA)
  • Microbiology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
AT98306431T 1997-08-26 1998-08-12 Neospora impstoff ATE277631T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US5695697P 1997-08-26 1997-08-26

Publications (1)

Publication Number Publication Date
ATE277631T1 true ATE277631T1 (de) 2004-10-15

Family

ID=22007613

Family Applications (1)

Application Number Title Priority Date Filing Date
AT98306431T ATE277631T1 (de) 1997-08-26 1998-08-12 Neospora impstoff

Country Status (16)

Country Link
US (2) US6787146B2 (de)
EP (2) EP1477184A3 (de)
JP (1) JP3049016B2 (de)
CN (1) CN1211449A (de)
AR (1) AR016396A1 (de)
AT (1) ATE277631T1 (de)
AU (1) AU764455B2 (de)
BR (1) BR9803232A (de)
CA (1) CA2245425C (de)
DE (1) DE69826593T2 (de)
DK (1) DK0898969T3 (de)
ES (1) ES2227783T3 (de)
NZ (1) NZ331529A (de)
PT (1) PT898969E (de)
TW (2) TWI228419B (de)
ZA (1) ZA987662B (de)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BR9812976A (pt) 1997-10-20 2000-08-08 Bayer Ag Vacina de neospora
EP0953641A3 (de) * 1998-03-26 2002-03-13 Pfizer Products Inc. Für Neospora Proteine kodierende polynukleotid Moleküle
ME00810B (me) * 2002-08-26 2012-03-20 Zoetis Services Llc Vakcina za infekcije respiratornog i reproduktivnog sistema kod stoke
AU2003301526A1 (en) * 2002-10-25 2004-05-13 University Of Connecticut Health Center Immunotherapy of cancer through controlled cell lysis
WO2005118884A1 (en) * 2004-05-28 2005-12-15 The United States Of America As Represented By The Secretary Of The Navy A method for the rapid diagnosis of infectious disease by detection and quantitation of microorganism induced cytokines
ES2319242B1 (es) 2005-12-23 2009-12-01 Laboratorios Hipra, S.A. Aislado avirulento de neospora canimum y sus usos.
ES2326770B1 (es) 2007-07-13 2010-07-26 Universidad Complutense De Madrid Uso de un nuevo aislado de neospora caninum para el desarrollo de pruebas de diagnostico y para la fabricacion de productos para el tratamiento y prevencion de la infenccion causada por neospora.
CN101831495B (zh) * 2010-04-30 2013-06-19 新疆出入境检验检疫局检验检疫技术中心 一种牛新孢子虫病的检测方法及应用
EP2708237A1 (de) * 2012-09-17 2014-03-19 Université de Droit et de la Santé de Lille 2 Pharmazeutische Zusammensetzung zu deren Verwendung bei der präventiven Behandlung von Infektionen, die durch einen intrazellularen Krankheitserreger, speziell durch Toxoplasma gondii, verursacht werden
WO2014182872A1 (en) 2013-05-08 2014-11-13 Protatek International, Inc. Vaccine for pcv2 and mycoplasma
EP3368070B9 (de) 2015-10-28 2023-10-18 Universidad Complutense De Madrid Neospora-impstoffzusammensetzung
JP2019533995A (ja) 2016-10-05 2019-11-28 ゾエティス・サービシーズ・エルエルシー 強力な生ワクチンとして使用するための安定に脱水された原生動物を提供する凍結乾燥方法

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5643718A (en) * 1993-11-04 1997-07-01 The Board Of Trustees Of The Leland Stanford Junior University Transfection and genetic manipulations in obligate intracellular parasites
US5707617A (en) * 1994-03-21 1998-01-13 The Regents Of The University Of California Bovine neospora isolates
US5889166A (en) * 1996-05-10 1999-03-30 The Regents Of The University Of California Recombinant neospora antigens and their uses
US6743430B1 (en) 1995-03-29 2004-06-01 Richard E. Parizek Multicomponent vaccine containing clostridial and non-clostridial organisms in a low dose
CA2184132C (en) 1995-09-21 2011-03-15 Kristina J. Hennessy An adjuvanted vaccine which is substantially free of non-host albumin
AU7677896A (en) 1995-11-09 1997-05-29 Trustees Of Dartmouth College A vaccine against toxoplasma gondii
ES2224210T3 (es) * 1996-11-12 2005-03-01 Pfizer Inc. Vacuna de neospora viva atenuada.

Also Published As

Publication number Publication date
DE69826593T2 (de) 2005-02-10
DK0898969T3 (da) 2005-01-17
BR9803232A (pt) 2000-01-11
JPH11130683A (ja) 1999-05-18
AU764455B2 (en) 2003-08-21
EP0898969A2 (de) 1999-03-03
ZA987662B (en) 2000-02-25
AR016396A1 (es) 2001-07-04
EP1477184A3 (de) 2006-04-12
US20020058046A1 (en) 2002-05-16
CA2245425A1 (en) 1999-02-26
TW200305433A (en) 2003-11-01
DE69826593D1 (de) 2004-11-04
EP1477184A2 (de) 2004-11-17
US20040223982A1 (en) 2004-11-11
EP0898969A3 (de) 2001-02-07
AU8188498A (en) 1999-03-11
EP0898969B1 (de) 2004-09-29
PT898969E (pt) 2005-01-31
TWI228419B (en) 2005-03-01
CN1211449A (zh) 1999-03-24
CA2245425C (en) 2006-12-12
US6787146B2 (en) 2004-09-07
ES2227783T3 (es) 2005-04-01
NZ331529A (en) 1999-03-29
JP3049016B2 (ja) 2000-06-05

Similar Documents

Publication Publication Date Title
NO20003303L (no) Vaksine
ID22500A (id) Turunan sulfonamida
ID24430A (id) Turunan-turunan benzamidina
DE69831181D1 (de) Positionsbestimmung
DE19810476B4 (de) Laryngomaske
ATA93198A (de) Fluoxetinpellets
ID23173A (id) Turunan pirol trisiklik atau pirazol
NO20006191D0 (no) Vaksine
DE69806297D1 (de) Bilddekodiergerät
DE69733411D1 (de) Störisolierungsschaltung
ATE277631T1 (de) Neospora impstoff
DE59802506D1 (de) Weichspülmittelzusammemsetzung
DE59801498D1 (de) Dioxacycloalkan-8-one
DE59803185D1 (de) Baulaser
DE59710388D1 (de) Mikropolarimeter
NO20005599L (no) Vaksine
ATA111897A (de) Kimme
ATE236897T1 (de) 3-benzylpiperidine
ATA112597A (de) Snowboard - bindung
ATA86797A (de) Verschleissschuh
DE59800820D1 (de) Stiellose kniegelenkendoprothese
BR9701194A (pt) Hidrociclo
ATA46498A (de) Kunststoffgleitbahn
BR7701838U (pt) Monotocentrociclo
FI970874A0 (fi) Vattenkvarn

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 0898969

Country of ref document: EP

REN Ceased due to non-payment of the annual fee
RZN Patent revoked